Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
| Operating Expenses | 8,616 | 7,492 | 8,546 | 10,262 | 9,657 |
| Operating Income | -8,616 | -7,492 | -8,546 | -10,262 | -9,657 |
| Interest Expense | 25 | 1 | 29 | 14 | 17 |
| Other Income | 80 | -33 | -50 | 217 | 9 |
| Pre-tax Income | -8,561 | -7,526 | -8,625 | -10,059 | -9,665 |
| Net Income Continuous | -8,561 | -7,526 | -8,625 | -10,059 | -9,665 |
| Net Income Discontinuous | -613 | N/A | N/A | N/A | N/A |
| Minority Interests | 189 | N/A | N/A | N/A | N/A |
| Net Income | $-8,985 | $-7,526 | $-8,625 | $-10,059 | $-9,665 |
| EPS Basic Total Ops | -0.35 | -0.35 | -0.45 | -0.55 | -0.55 |
| EPS Basic Continuous Ops | -0.35 | -0.35 | -0.45 | -0.55 | -0.55 |
| EPS Diluted Total Ops | -0.35 | -0.35 | -0.45 | -0.55 | -0.55 |
| EPS Diluted Continuous Ops | -0.35 | -0.35 | -0.45 | -0.55 | -0.55 |
| EBITDA(a) | $-8,325 | $-7,400 | $-8,431 | $-9,915 | $-9,514 |